Aug 2
|
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows
|
Aug 1
|
Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer
|
Aug 1
|
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
|
Aug 1
|
Stocks to watch next week: BP, Diageo, Disney, Uber and WPP
|
Aug 1
|
Stock Market News for Aug 1, 2025
|
Aug 1
|
Reddit, Coinbase, Novo Nordisk - Trending Stocks
|
Aug 1
|
Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
|
Aug 1
|
Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus
|
Aug 1
|
Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It”
|
Jul 31
|
1 Blue-Chip Dividend Stock That Still Has Room to Run
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
Jul 31
|
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
|
Jul 31
|
Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
|
Jul 31
|
Trump pressures 17 pharma CEOs to cut US drug prices
|
Jul 31
|
Chicken Pox Market Analysis and Forecast 2025-2035 | Varicella Vaccine Demand Soars as Global Health Initiatives Expand
|
Jul 31
|
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
|
Jul 31
|
Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
|
Jul 31
|
Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
|
Jul 31
|
Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM
|
Jul 30
|
AI Stock With Unique Focus Joins Palantir, Nvidia On 3 Elite Lists
|